This secondary analysis of the PETACC-3 trial examines the association of sex with incidence and severity of chemotherapy-related toxic effects in patients with stage II and III colorectal cancer treated with fluorouracil and leucovorin with or without irinotecan hydrochloride.
https://ift.tt/2KTDBjB
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου